The gentler side effect profile may relate to the different mechanisms
The term slope is used by analysts to describe scenarios where revenue erosion is gradual spread over several years rather than months
However, as of March 2025, the FDA has prohibited compounding pharmacies from dispensing and distributing compounded tirzepatide now that the Zepbound shortage is over
Research suggests tirzepatide may lead to greater average weight loss than semaglutide for some adults with obesity or overweight
175 Recent advancements include the development of neuroprotective agents 114,176 with potentially profound implications for patient care
No validated human pharmacokinetics A human half-life, bioavailability, tissue distribution, metabolic pathway and exposure-response relationship have not been established through a published clinical programme